5080 studies found for:    "Lung Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Lung Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Conditions: Cancer of the Lung;   Lung Cancer;   Lung Neoplasms;   Adenocarcinoma of the Lung;   Non Small Cell Carcinoma of the Lung;   Small Cell Carcinoma of the Lung
Intervention:
2 Completed
Has Results
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Dysgeusia;   Taste Disorders;   Lung Neoplasms;   Small Cell Lung Carcinoma
Intervention:
3 Unknown  Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Procedure: Fractionated Stereotactic Radiotherapy
4 Completed FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Intervention: Drug: FR901228
5 Completed
Has Results
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Chemotherapy-Induced Thrombocytopenia;   Non-Small Cell Lung Cancer;   Cancer;   Lung Neoplasms;   Oncology;   Solid Tumors;   Thrombocytopenia
Interventions: Biological: Romiplostim;   Drug: Placebo;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin
6 Completed Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
Conditions: Adenocarcinoma;   Non-Small-Cell Lung Carcinoma;   Lung Neoplasms
Intervention: Drug: Motexafin Gadolinium
7 Completed A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small Cell-Lung;   Lung Neoplasms;   Lung Cancer;   Respiratory Tract Neoplasms
Interventions: Biological: AV-299 + gefitinib;   Drug: Gefitinib
8 Active, not recruiting Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer
Conditions: Lung Carcinoma;   Lung Neoplasm;   Malignant Lung Neoplasm
Intervention: Other: cytology specimen collection procedure
9 Completed Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Conditions: Recurrent Colon Cancer;   Extensive Stage Small Cell Lung Cancer;   Stage III Pancreatic Cancer;   Stage III Rectal Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Pancreatic Cancer;   Recurrent Rectal Cancer;   Stage III Non-small Cell Lung Cancer;   Stage I Pancreatic Cancer;   Stage II Non-small Cell Lung Cancer;   Stage IVB Pancreatic Cancer;   Stage II Pancreatic Cancer;   Stage III Colon Cancer;   Stage IVA Pancreatic Cancer
Interventions: Drug: Detox-B adjuvant;   Drug: ras peptide cancer vaccine
10 Recruiting MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
Conditions: Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Lung Cancer;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Metastatic Cancer to the Lung
Intervention: Procedure: Microwave ablation
11 Not yet recruiting Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Non-small-cell Lung;   Adenocarcinoma;   Squamous Cell Carcinoma
Intervention:
12 Unknown  Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer;   Lung Cancer;   Stage IIIA Non Small Cell Lung Cancer;   Stage IIIB Non Small Cell Lung Cancer
Intervention: Drug: S-3304
13 Withdrawn GRN1005 for Brain Metastases From Breast or Lung Cancer
Conditions: Breast Cancer;   Lung Neoplasms;   Breast Neoplasms;   Lung Cancer
Interventions: Drug: Trastuzumab;   Drug: GRN 1005
14 Recruiting Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Radiation: Radiation therapy
15 Completed Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention: Procedure: Exhaled Breath Sampling
16 Recruiting Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Conditions: Adenocarcinoma of the Lung;   Extensive Stage Small Cell Lung Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Intervention: Drug: Ponatinib
17 Not yet recruiting Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients
Conditions: Carcinoma;   Non-small-cell Lung Cancer;   Lung Neoplasms
Intervention:
18 Completed Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma;   Carcinoma, Non-Small Cell Lung;   Lung Neoplasms
Intervention: Drug: EKB-569
19 Completed Lung Cancer Informational Study (LCIS)
Conditions: Cancer;   Enhanced Care;   Decision-Making;   Advance Lung Cancer;   Stage III Lung Cancer;   Stage IV Lung Cancer
Interventions: Behavioral: Enhance Care;   Behavioral: Usual Care
20 Completed Study of Arsenic Trioxide in Small Cell Lung Cancer
Conditions: Lung Cancer;   Cancer of Lung;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Small Cell
Intervention: Drug: Arsenic Trioxide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years